UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 10/2011, Volume 306, Issue 14, pp. 1549 - 1556
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Follow-Up Studies | Humans | Middle Aged | Male | Risk | Vitamin E - adverse effects | Incidence | Prostatic Neoplasms - epidemiology | Antioxidants - administration & dosage | Vitamin E - administration & dosage | Antioxidants - adverse effects | Aged | Dietary Supplements - adverse effects | Prostatic Neoplasms - prevention & control | Selenium - administration & dosage | Mens health | Vitamin E | Clinical trials | Selenium | Comparative analysis | Prostate cancer | Risk factors | Diets | Intervention | Prevention | prostate cancer | Age | Vitamins | Cancer
Journal Article
The lancet oncology, ISSN 1470-2045, 2013, Volume 14, Issue 9, pp. 893 - 900
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Bone Neoplasms - mortality | Neoplasms, Hormone-Dependent - mortality | Prostatic Neoplasms - pathology | Prognosis | Double-Blind Method | Follow-Up Studies | Humans | Middle Aged | Bone Neoplasms - secondary | Pyrrolidines - administration & dosage | Male | Survival Rate | Prostatic Neoplasms - mortality | Taxoids - administration & dosage | Neoplasm Grading | Castration | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Hormone-Dependent - pathology | Adult | Aged | Bone Neoplasms - drug therapy | Neoplasms, Hormone-Dependent - drug therapy | Prostatic Neoplasms - drug therapy | Product development | Hospitals, Veterans | Prostate cancer | Docetaxel | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 7, pp. 603 - 610
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Gynecology. Andrology. Obstetrics | General aspects | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Male genital diseases | Tumors | Prostatic Neoplasms - pathology | Follow-Up Studies | Humans | Kaplan-Meier Estimate | Male | Risk | Survival Rate | 5-alpha Reductase Inhibitors - therapeutic use | Prostatic Neoplasms - mortality | Incidence | Prostatic Neoplasms - epidemiology | Neoplasm Grading | Finasteride - therapeutic use | Prostatic Neoplasms - prevention & control | Prevention | Finasteride | Patient outcomes | Clinical trials | Dosage and administration | Research | Prostate cancer | Disease prevention | Mens health | Biopsy | Men | Survival | Cancer therapies | Prostate | Index Medicus | Abridged Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 05/2018, Volume 319, Issue 18, pp. 1880 - 1888
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Double-Blind Method | Follow-Up Studies | Neoplasm Recurrence, Local - prevention & control | Neoplasm Invasiveness | Deoxycytidine - administration & dosage | Humans | Middle Aged | Carcinoma, Papillary - drug therapy | Male | Sodium Chloride - administration & dosage | Urinary Bladder Neoplasms - drug therapy | Carcinoma, Papillary - pathology | Antimetabolites, Antineoplastic - administration & dosage | Incidence | Antimetabolites, Antineoplastic - adverse effects | Urinary Bladder Neoplasms - pathology | Deoxycytidine - adverse effects | Female | Aged | Neoplasm Recurrence, Local - epidemiology | Administration, Intravesical | Deoxycytidine - analogs & derivatives | Urothelium | Urothelial cancer | Gemcitabine | Toxicity | Invasiveness | Cytology | Clinical trials | Bladder | Muscles | Bladder cancer | Patients | Cancer surgery | Rank tests | Mens health | Motivation | Tumors | Cancer
Journal Article
The New England journal of medicine, ISSN 0028-4793, 07/2003, Volume 349, Issue 3, pp. 215 - 224
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Chemotherapy | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Prostatic Neoplasms - pathology | Humans | Middle Aged | 5-alpha Reductase Inhibitors | Male | Morbidity | Prostate-Specific Antigen - blood | Prostatic Neoplasms - epidemiology | Antineoplastic Agents, Hormonal - adverse effects | Prostate - pathology | Finasteride - adverse effects | Biopsy | Antineoplastic Agents, Hormonal - therapeutic use | Aged | Finasteride - therapeutic use | Prostatic Neoplasms - prevention & control | Prostatic Neoplasms - chemically induced | Neoplasms, Hormone-Dependent - prevention & control | Prevention | Evaluation | Development and progression | Finasteride | Prostate cancer | Men | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 05/2004, Volume 350, Issue 22, pp. 2239 - 2246
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Gynecology. Andrology. Obstetrics | General aspects | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Male genital diseases | Tumors | Prostatic Neoplasms - pathology | Prevalence | Humans | Middle Aged | Male | Risk | Prostate-Specific Antigen - blood | Prostatic Neoplasms - epidemiology | Prostate - pathology | Biopsy | Antineoplastic Agents, Hormonal - therapeutic use | Aged, 80 and over | Prostatic Neoplasms - blood | Aged | Finasteride - therapeutic use | Prostatic Neoplasms - prevention & control | Clinical trials | Medical diagnosis | Prostate cancer | Men | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 04/2013, Volume 368, Issue 14, pp. 1314 - 1325
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Gynecology. Andrology. Obstetrics | General aspects | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Male genital diseases | Tumors | Confidence Intervals | Follow-Up Studies | Anilides - adverse effects | Humans | Middle Aged | Male | Gonadotropin-Releasing Hormone - analogs & derivatives | Nitriles - administration & dosage | Antineoplastic Agents, Hormonal - adverse effects | Neoplasm Metastasis - drug therapy | Penile Erection - drug effects | Gonadotropin-Releasing Hormone - therapeutic use | Goserelin - adverse effects | Prostatic Neoplasms - drug therapy | Goserelin - administration & dosage | Prostatic Neoplasms - pathology | Tosyl Compounds - administration & dosage | Drug Administration Schedule | Antineoplastic Agents, Hormonal - administration & dosage | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Tosyl Compounds - adverse effects | Anilides - administration & dosage | Survival Analysis | Quality of Life | Aged | Androgen Antagonists - administration & dosage | Nitriles - adverse effects | Usage | Care and treatment | Patient outcomes | Androgen suppression therapy | Drug therapy | Prostate cancer | Methods | Cancer | Statistical analysis | Mental disorders | Prostate-specific antigen | Clinical trials | Patients | Survival | Quality of life | Metastases | Androgens | Castration | Stem cells | Luteinizing hormone | Prostate | Index Medicus | Abridged Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 11/2006, Volume 296, Issue 19, pp. 2329 - 2335
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Radiotherapy Dosage | Prostatic Neoplasms - radiotherapy | Follow-Up Studies | Prostatic Neoplasms - surgery | Neoplasm Invasiveness | Humans | Middle Aged | Male | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Cross-Over Studies | Neoplasm Metastasis | Survival Analysis | Prostatic Neoplasms - blood | Adult | Prostatectomy | Aged | Radiotherapy, Adjuvant | Survival analysis | Surgery | Clinical trials | Radiation therapy | Prostate cancer | Clinical outcomes | Tumors
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 12/2005, Volume 294, Issue 23, pp. 2996 - 3002
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Middle Aged | Risk Factors | Proportional Hazards Models | Cardiovascular Diseases - epidemiology | Male | Aged | Erectile Dysfunction - epidemiology | Cohort Studies | Cardiovascular disease | Reproductive system | Sexual disorders | Risk factors
Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2019, Volume 380, Issue 4, pp. 393 - 394
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Early Detection of Cancer | Humans | Middle Aged | Male | 5-alpha Reductase Inhibitors - therapeutic use | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Finasteride - adverse effects | Neoplasm Grading | 5-alpha Reductase Inhibitors - adverse effects | Finasteride - therapeutic use | Prostatic Neoplasms - prevention & control | Prostatic Neoplasms - chemically induced | Disease prevention | Prostate | Prostate cancer | Men | Tumors | Long-term effects | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 3, pp. 270 - 271
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Male | Prostatectomy | Watchful Waiting | Prostatic Neoplasms - surgery | Humans | Prostatic Neoplasms - mortality | Treatment outcome | Evaluation | Care and treatment | Usage | Diagnosis | Prostate cancer | Confidence intervals | Wilt | Prostate-specific antigen | Mortality | Men | Prostate | Index Medicus | Abridged Index Medicus
Journal Article